Sarepta Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 06 2020 - 8:30AM
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision
genetic medicine for rare diseases, today announced that senior
management will present at the 38th Annual J.P. Morgan Healthcare
Conference in San Francisco, California on Monday, January 13, 2020
at 12:30 p.m. E.T. / 9:30 a.m. P.T. Following the presentation
there will be a Q&A session starting at 1:00 p.m. E.T. / 10:00
a.m. P.T.
The presentation and Q&A session will be
webcast live under the investor relations section of Sarepta’s
website at www.sarepta.com and will be archived there
following the presentation for 90 days. Please connect to Sarepta's
website several minutes prior to the start of the broadcast to
ensure adequate time for any software download that may be
necessary.
About Sarepta
TherapeuticsSarepta is at the forefront of precision
genetic medicine, having built an impressive and competitive
position in Duchenne muscular dystrophy (DMD) and more recently in
gene therapies for limb-girdle muscular dystrophy diseases (LGMD),
Charcot-Marie-Tooth (CMT), MPS IIIA and other CNS-related
disorders, totaling over 20 therapies in various stages of
development. The Company’s programs and research focus span several
therapeutic modalities, including RNA, gene therapy and gene
editing. Sarepta is fueled by an audacious but important mission:
to profoundly improve and extend the lives of patients with rare
genetic-based diseases. For more information, please visit
www.sarepta.com.
Internet Posting of
Information
We routinely post information that may be
important to investors in the 'For Investors' section of our
website at www.sarepta.com. We encourage investors and
potential investors to consult our website regularly for important
information about us.
Source: Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc.Investors: Ian Estepan, 617-274-4052
iestepan@sarepta.com
Media:Tracy Sorrentino, 617-301-8566tsorrentino@sarepta.com
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Apr 2023 to Apr 2024